Hancock Whitney’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,692
Closed -$303K 768
2025
Q4
$303K Sell
3,692
-411
-10% -$32K 0.01% 667
2025
Q3
$308K Sell
4,103
-20,242
-83% -$1.51M 0.01% 661
2025
Q2
$1.8M Buy
24,345
+1,521
+7% +$106K 0.03% 308
2025
Q1
$1.84M Buy
22,824
+435
+2% +$37.4K 0.06% 221
2024
Q4
$1.75M Buy
22,389
+1,047
+5% +$89K 0.06% 224
2024
Q3
$2M Buy
21,342
+517
+2% +$43.4K 0.06% 202
2024
Q2
$1.62M Buy
20,825
+3,230
+18% +$263K 0.06% 223
2024
Q1
$1.6M Buy
17,595
+279
+2% +$23.2K 0.06% 230
2023
Q4
$1.34M Sell
17,316
-1,666
-9% -$117K 0.05% 258
2023
Q3
$1.29M Buy
18,982
+1,976
+12% +$144K 0.05% 248
2023
Q2
$1.38M Buy
17,006
+13,466
+380% +$1.07M 0.05% 250
2023
Q1
$291K Buy
+3,540
New +$253K 0.01% 550

Other funds holding GEHC

Hancock Whitney's GEHC Position: Q1 2026 in Review

Hancock Whitney sold out of GE HealthCare (GEHC) in Q1 2026, closing a stake of 3,692 shares — an estimated $303K sold.

Hancock Whitney first reported a position in GEHC in Q1 2023 and held it in 12 quarters. The position peaked at $2M in Q3 2024. 1,272 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Hancock Whitney reported no remaining GE HealthCare position as of Q1 2026 after selling out during the quarter.
  • Hancock Whitney sold 3,692 GE HealthCare shares in Q1 2026, an estimated $303K.
  • Hancock Whitney first reported a position in GE HealthCare in Q1 2023 and held it in 12 quarters.
  • Hancock Whitney's GE HealthCare position peaked at $2M in Q3 2024.
  • 1,272 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Hancock Whitney's 13F filing for Q1 2026, filed 15 May 2026.